PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III, page-835

Fair Call ONG , you have always provided well balanced posts with detailed reasoning. Leave the door open behind you as there may be more following after the Quarterly.

Company has total disregard for SH and Market Updates and Communication shouldn't require reading between the lines and decoding.

Biggest recent let down is Management announcing moving toward a Human Phase II Covid Trial burried on line 4 of the MND release, there are ASX Biotechs that would give their right arm to make that announcement.. Their CEO would be front and center heralding the achievement,, The Market have tagged PAA as a Research institute and that's why Volume and interest is non existent..

Originally posted by rodad: ↑

Always a risk when there is no liquidity in a stock , Hope is not well formulated strategy? but you can see from reading the last 3 Q that nothing is happening at any great pace..
Now the 6 clinics in 4 countries Covid fairy tale is over , Human Cancer Trial has been touted since 2017, even an individual CR with JP @12c for Human Pills and Human Cancer Trial??? K9 Dogs USA? NZ? Kim?
The OHD Flux capacitor has gone back to the future ........
But as we know many here believe in the Technology and benefits of MPL just Management have demonstrated no need to rush , heck the death toll from Covid alone would make any one of us cringe... 551 million cases , 7 million deaths..... but hey at some stage in the not to distant future PAA will be trialing on a Mouse after 26 months since the Remarkable Results,,, almost criminal........

Who stated Roger is in Australia?
Who stated he is going to complete an Investor Roadshow?